SeqOnce Biosciences is a privately held company located in Pasadena, California. Our core competencies, including enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development.
SeqOnce Biosciences was formed in 2014 by Joseph Dunham, Ph.D, a researcher at the University of Southern California and Chris Angermayer, a former portfolio manager and investment analyst. The founders are dedicated to building a team of individuals who are leaders in the industry, thereby enabling SeqOnce to become a preeminent player in the NGS sample preparation market.
SeqOnce Biosciences was formed in 2014 by Joseph Dunham, Ph.D, a researcher at the University of Southern California and Chris Angermayer, a former portfolio manager and investment analyst. The founders are dedicated to building a team of individuals who are leaders in the industry, thereby enabling SeqOnce to become a preeminent player in the NGS sample preparation market.
Location: United States, California, Pasadena
Employees: 11-50
Total raised: $1M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Wavemaker ... | wavemaker3... |
| - | Embark Ven... | embark.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.05.2018 | Seed | $1M | - |
Mentions in press and media 6
| Date | Title | Description |
| 10.03.2021 | SeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern | |
| 28.01.2021 | SeqOnce BioSciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant | |
| 14.05.2018 | Term Sheet — Monday, May 14 | MONDAY MADNESS Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop NOW, WHAT? Xerox Corp called off its planned $6.1 billion merger with Fujifilm Holdings Corp in a settlement with a... |
| 14.05.2018 | SeqOnce Biosciences Finds $1M In Seed Funding | Pasadena-based SeqOnce Biosciences, which is developing next generation sequencing technology, has raised $1M in a seed funding round, according to the company. The funding came from Pasadena-based Mount Wilson Ventures (MWV), a new venture... |
| 11.05.2018 | SeqOnce Biosciences Secures $1M Seed Financing | SeqOnce Biosciences, Inc., a Pasadena, CA-based a life science company, completed a $1m seed funding. The round was led by Mount Wilson Ventures (MWV). In conjunction with the financing, Mike Giardello will join the Board of Directors of Se... |
| 30.04.2018 | SeqOnce BioSciences Raises $1M | - |